Cooper Companies Announce Second Quarter 2018 Results
The financial results for the Cooper Companies for Q2 2018 shows that they report a 21% year-over-year revenue increase to $631.3 million.
CooperVision revenue was up 14% year-over-year (to $467.5 million) and CooperSurgical revenue was up 44% to $163 million.
CooperVision’s largest revenue increases came from the EMEA (Europe, Middle East and Africa) region and the Asia Pacific region, at 20%. Revenue in the Americas increased by 7% to $183.6 million. The largest increase in revenue came from the single-use sphere category, a 19% year-over-year increase.
Albert White, Cooper’s president and chief executive officer said, “This was a strong quarter with improving profitability and strong cash flow. CVI posted solid revenue growth driven by success with its daily silicone hydrogel lenses and, CSI posted a solid quarter driven by double digit growth in PARAGARD® and fertility solutions. As we move into the second half of the year, we are well positioned to continue posting strong results.”